"The only Professional Fundraising Organisation
to include dedicated donor monitoring as part of what we do"
We are Contact, the charity for families with disabled children
We were founded in the 1970s by families of disabled children, who recognised that even if their child's conditions were different, they shared a common experience - of being a family with a disabled child. They understood how important it is to support each other.
A lot has changed since then but some things haven't changed nearly enough. There is a desperate lack of services and support for the 620,000 parents in...
Posted on: 27/09/2017 Categories: Charity News
Posted on: 27/09/2017 Categories: Client News
Charcot-Marie-Tooth disease - an inherited neurological disorder
Estimates suggest around 25,000 people in the UK have Charcot-Marie-Tooth disease (CMT).1 They usually start to have symptoms – which can include muscle weakness and numbness in the feet, arms and hands – during childhood or adolescence. Symptoms slowly get worse and more disabling over time, making everyday tasks increasingly difficult. Professor David Bennett, of the University of Oxford, is in the early stages...
Posted on: 19/09/2017 Categories: Charity News
The Sheikh Zayed Regional Eye Care Centre in The Gambia has marked its 10-year anniversary with a high-profile event to celebrate its success providing eye health services and training in the region.
The centre aims to improve the eye health of the population of Health for Peace Initiative (HFPI) member countries by developing human resources for eye health, medical treatment and surgical intervention.
The anniversary event on 25 August coincided with the graduation ceremony of...
Posted on: 13/09/2017 Categories: Charity News
The European Medicines Agency (EMA) has licensed cladribine (also known as Mavenclad) to treat people with highly active relapsing MS.
The National Institute for Health and Care Excellence (NICE) will now decide whether to make it available on the NHS in England and Wales. The Scottish Medicines Consortium (SMC) will decide for Scotland.
How does it work?
Cladribine is currently used as an anti-cancer drug.
In MS, the body's own immune cells mistakenly attack the...
Posted on: 06/09/2017 Categories: Charity News
Quick links >>